Roche quits ABPI

June 30, 2009
Research and Development, Sales and Marketing ABPI, Roche, UK

Roche is to give up its ABPI membership in a surprise move that could undermine the UK’s system of industry …

Is the law good for your health?

June 30, 2009
Research and Development Les Rose, law, science

 A lawyer once told me that the law has nothing to do with morals. This wasn’t really a surprise, but …

Bayer signs deal with Celera on cancer targets

June 30, 2009
Research and Development, Sales and Marketing Bayer, Celera

Bayer Schering Pharma has signed a deal with Celera to give it access to five cancer-related targets for therapeutic development …

Satchell to lead Rock Medical Communications

June 30, 2009
Medical Communications Creston, Med Comms, Rock Medical

Rock Medical Communications has been launched as part of the Creston Health group. The company will deliver medical education programmes, …

PPD backs away from new facility lease

June 30, 2009
Research and Development CRO, PPD

PPD has cancelled plans to occupy a facility at the North Carolina Research Campus in the US, blaming construction delays …

Public fear for NHS funding in the recession

June 29, 2009
NHS, healthcare

The public has grave fears over the future of NHS funding in light of the recession, according to a public …

Contract research sector: news in brief

June 29, 2009
Research and Development CRO, chiltern

Pharmafocus presents a round-up of developments in the contract research sector, including a successful IPO by Medidata, Pierrel's imminent acquisition …

Succinct launches sister consultancy

June 29, 2009
Medical Communications Consultancy, Succint

Medical education agency Succinct Communications has launched a sister company, Succinct Consulting. Succinct Consulting says it will help international pharmaceutical …

Pharma companies feeling ‘supply chain pain’, says UPS

June 26, 2009
Manufacturing and Production supply chain

Regulatory pressures are at the top of the list of supply chain concerns voiced by pharmaceutical manufacturers in an annual …

Cervical cancer awareness campaign targets GPs and nurses

June 26, 2009
Medical Communications, Sales and Marketing NHS, vaccines

GPs and practice nurses are to be targeted in a government awareness campaign to ensure cervical cancer is spotted earlier …

Novartis gains approval for first Japanese biosimilar

June 25, 2009
Research and Development, Sales and Marketing Novartis, generics

Japan has approved its first biosimilar medicine – the recombinant human growth hormone somatropin from Novartis' generic arm Sandoz. The …

Merck takes aim at neglected tropical diseases

June 25, 2009
Research and Development, Sales and Marketing Africa, Merck, Orphan

Merck & Co is participating in two projects designed to help improve healthcare in Africa. The pharma giant will join …

GSK signs arthritis drug development collaboration

June 25, 2009
Research and Development, Sales and Marketing Deals, GSK

GlaxoSmithKline and Oxford-based Chroma Therapeutics are linking up to identify small molecule therapeutics in a bid to combat conditions like …

Dendreon sets aside $50m for Provenge facility

June 24, 2009
Manufacturing and Production Dendreon, US

US biotechnology company Dendreon revealed its confidence in lead drug Provenge for prostate cancer with the announcement it will invest …

Pharma agrees cost-saving deal with US government

June 24, 2009
Sales and Marketing Medicare, US, US healthcare, healthcare

Drug makers have agreed with the US government to spend $80 billion over the next ten years in a bid …

Helsinn restructures API units in Switzerland, Ireland

June 23, 2009
Manufacturing and Production Helsinn

Pharmaceutical group Helsinn is planning to expand its manufacturing capabilities with a new round of investment at a production facility …

Working Life: Kevin Crowe

June 23, 2009
Sales and Marketing Merck Serono, WL, sales force effectiveness

How did you find your way into your current role?I have worked for several years in the Canadian pharmaceutical industry …

Astellas signs European deal in pain management

June 23, 2009
Research and Development, Sales and Marketing Astellas

Astellas has struck a deal with Californian company NeurogesX to market in Europe a treatment for pain linked to peripheral …

Pharma quotas ‘do not affect parallel trade’

June 23, 2009
Manufacturing and Production EAEPC, parallel trade

 The stable market for parallel imports in recent years suggests pharma quotas on wholesalers have not dampened the trade, according to a parallel distributor …

The Gateway to Local Adoption Series

Latest content